Capricor Therapeutics, Inc. earnings per share and revenue

CAPR earnings per share for the last quarter are -0.38 USD whereas the estimation was -0.36 USD which accounts for -6.05% surprise. Company revenue for the same period amounts to 2.26 M USD despite the estimated figure of 4.28 M USD. Estimated earnings per share for the next quarter are -0.18 USD, and revenue is expected to reach 11.52 M USD. Also watch annual changes over time to get a bigger picture of CAPR earnings per share and revenue dynamics.